Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Peripheral artery disease Companies

Peripheral Artery Disease (PAD) is a condition characterized by the narrowing or blockage of arteries that supply blood to the limbs, typically the legs. Companies involved in the management and treatment of Peripheral Artery Disease often offer medical devices, medications, and interventional therapies to address the symptoms and complications associated with this condition.

Latest Peripheral Artery Disease Companies Update

Oct 2023: The benefits of a comeback in elective treatments should be evident in Boston Scientific's quarterly results, allaying concerns that the medical equipment manufacturer would suffer from the rising popularity of weight-loss medications. Concerns that well-liked new GLP-1 medications, such as Novo Nordisk's Ozempic and Wegovy, which are licensed to treat diabetes and weight reduction, may eat into the market for devices used by diabetic patients as well as bariatric surgery, have caused shares in the entire industry to plummet in recent months. Due to its very minor bariatric exposure, analysts have stated that Boston Scientific is unlikely to encounter any pressure from GLP-1s in the third quarter or soon and that it is uncertain how this may affect the company's heart devices in the long run.

Feb 2023: The market leader in medical radar monitoring and imaging technology (ReDSTM), Sensible Medical Innovations, and Terumo India, the Indian division of Terumo Corporation, an international innovator in medical technology, announced their partnership, which gives Terumo India exclusive distribution rights for ReDS ProTM and knowledge-sharing of ReDSTM technology in India. Patients' absolute lung fluid volume is measured with ReDSTM Pro, and there is a substantial link between this measurement and the symptoms of congestive heart failure (CHF). Measuring using this non-invasive procedure takes forty-five seconds. ReDSTM Pro lung fluid assessment is just as accurate as CT scan measurements. ReDSTM Pro monitoring regularly and medication adjustment in heart failure patients may cut hospitalization rates by up to 30%. ReDSTM technology, originally developed for the Israeli military to see through barriers, has been repurposed for use in medicine.

List of Peripheral Artery Disease Key companies in the market

Philips N.V.,

Braun Melsungen AG,

Medtronic,

Bayer AG,

Boston Scientific Corporation,

Becton Dickinson and Company,

Terumo Medical Corporation,

Biotronik

Cardinal Health

Peripheral artery disease Market Highlights:

Peripheral artery disease Market Size

Peripheral artery disease Market Trends

Peripheral artery disease Market Analysis

Peripheral artery disease Market Share

Peripheral artery disease Market Highlights:

Peripheral artery disease Market Trends

Peripheral artery disease Market Analysis

Peripheral artery disease Market Share

Peripheral artery disease Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.